Significance Statement {#s1}
======================

Adolescence is a sensitive period of intense brain remodeling but it is unknown whether chronic disruption of sleep at this age has long-term structural effects on neural circuits. We measured the density of projections between the mouse secondary motor cortex and the rest of the brain, using viral-mediated axonal labeling followed by serial two-photon tomography. Mice underwent 5 days of chronic sleep restriction during early adolescence or slept undisturbed, and brain connectivity was assessed after the mice reached adulthood. The two groups did not differ in any global or homogeneous way. However, machine learning classification performance allows us to conclude that intricate and local heterogeneous changes do persist in adulthood due to chronic sleep restriction.

Introduction {#s2}
============

From early development to the end of adolescence, cortical circuits mature in stages, from early massive synaptogenesis and synaptic pruning, which result in large changes in the absolute number of synapses, to late synaptic refinement, when the initially homogeneous connectivity is reorganized without major changes in synaptic density ([@B19]; [@B45]; [@B54]; [@B55]). The end result of these processes is the adult anatomical connection matrix. Because this matrix is largely fixed, genetic or environmental factors that interfere with its establishment during development can have irreversible effects. Sleep disruption is rarely considered among these factors, perhaps because one can always sleep longer or deeper at a later time. Thus, few studies have tested the hypothesis that sleep disruption during development may impair the maturation and maintenance of brain circuits ([@B42]). For example, early experiments used drugs to disturb neonatal sleep, and found long-term neurochemical and behavioral effects, for instance on anxious behavior (for review, see [@B13]). However, these changes were likely caused not only by sleep loss, but also by other effects of the drugs used to enforce wake, many of which affect monoaminergic transmission ([@B13]). More recent experiments in kittens combined monocular deprivation with 1 week of rapid eye movement (REM) sleep deprivation before the end of the critical period and found a decrease in the size of neurons in the lateral geniculate nucleus of the thalamus ([@B50]), and similar results were obtained after total sleep deprivation ([@B37]). Chronic REM sleep deprivation alone also leads to the persistence of an immature form of synaptic potentiation in primary visual cortex, suggesting that sleep loss slows down the maturation of cortical circuits ([@B42]; [@B51]). Other studies in kittens found that a few hours of total sleep deprivation can immediately impair ocular dominance plasticity when sleep is prevented at the height of the critical period ([@B15]; [@B13]), and acute sleep deprivation in adolescent mice impairs the growth and maintenance of a subset of cortical spines formed after learning ([@B61]). Most of these experiments focused on preadolescent animals, and morphological and electrophysiological effects were assessed immediately or soon after the end of sleep deprivation. Thus, whether sleep loss during development leaves permanent structural changes in the adult brain was unknown, and even less known were the consequences of sustained sleep disruption during the sensitive period of adolescence ([@B36]).

Here we tested in mice whether the occurrence of chronic sleep restriction (CSR) during early adolescence has long-term effects on the adult anatomical connection matrix. In rodents, adolescence can be broadly defined as the period from weaning at postnatal day (P)21 to sexual maturity (∼P50--P60; [@B52]). Massive synaptogenesis and synaptic pruning occur mainly during the second postnatal week ([@B1]; [@B23]; [@B30]; [@B10]; [@B29]; [@B2]; [@B43]). Synaptic refinement follows in the third and fourth postnatal week, when the initially homogeneous connectivity is reorganized without major changes in synaptic density, and the functional optimization of cortical circuits continues throughout adolescence ([@B62]; [@B7]; [@B48]; [@B22]). Thus, during early adolescence (∼P21--P34) the anatomical connection matrix is still being refined. During the same time electroencephalographic (EEG) patterns across the sleep/wake cycle are similar to those seen in adults, and so are total daily sleep amounts (([@B17]; [@B14]; [@B32]); see Materials and Methods for details).

Materials and Methods {#s3}
=====================

Animals {#s3A}
-------

Five litters of C57BL/6J mice of the same age (*n*=32) were used in one single experiment that included 5 days of chronic sleep restriction (or sleep *ad libitum*) between P25 and P30, surgery for cortical injection of viral tracer at P44--P47, and perfusion for brain collection at P65--P68 ([Fig. 1*a*](#F1){ref-type="fig"}). All animal procedures followed the National Institutes of Health *Guide for the Care and Use of Laboratory Animals* and facilities were reviewed and approved by the IACUC of the University of Wisconsin-Madison, and were inspected and accredited by AAALAC.

![Experimental Timeline and MOs Projections. ***A***, Experimental timeline. Between P25 and P30, mice were allowed to sleep normally (C) or subjected to CSR. All mice were injected with AAV-GFP between P44 and P47, and each mouse was perfused exactly 3 weeks later. Middle, Right, The location of the viral injections on the skull and in a coronal brain section. A, Anterior; P, posterior; D, dorsal; V ventral; B, bregma. ***B***, Example of projections from MOs in two representative mice (C and CSR) 3 weeks after injection of AAV-GFP. Measurements are given in millimeters from bregma. Final analysis included 14 mice in each group.](enu0021620430001){#F1}

Experimental procedure {#s3B}
----------------------

At P21 mice were weaned, weighed, and housed in groups (4 per cage) in environmentally controlled conditions (12 h light/dark cycle; lights on at 8:00 A.M., room temperature 23 ± 1°C). At P24 body weight was rechecked and two groups of 16 animals, weight-balanced and sex-balanced, were created from the total pool of 32 mice. Each group was moved into a large cage (60 × 60 × 40 cm) where mice were free to interact. Food and water were provided *ab libitum* and replaced daily at 8 A.M. At P25, the control group was left undisturbed and video-monitored for 5 days, whereas the second group was subjected to 5 days of CSR starting at 8 A.M. At that time adolescent mice show EEG patterns across the sleep/wake cycle similar to those of adult mice, with low-voltage fast activity during wake and REM sleep and large slow waves during NREM sleep ([@B17]; [@B14]). Total daily sleep amounts in young adolescent mice are also at adult levels ([@B32]). On the other hand, REM sleep in mice continues to decline during early adolescence, and sleep deprivation is followed by an increase in sleep duration but not in sleep intensity, suggesting that the mechanisms of homeostatic sleep regulation are not fully mature ([@B32]).

CSR was enforced using multiple strategies to disrupt sleep. During the day, ecologically relevant stimuli were selected and presented to mice, including continuous exposure to novel objects, changes of cage and bedding, social interaction, and free access to multiple running wheels. Mild forced locomotion on a slowly rotating platform was used to restrict sleep during some parts of the night. The platform was located above a tray filled with 2--3 cm of water, and the rotation speed was low enough that mice could easily avoid falling into the water as long as they moved continuously. Heat lamps were placed ∼2 m above the platform to keep mice at the proper temperature. Video cameras and/or direct visual observation were used to monitor the mice at all times. Several mice were placed on the platform at the same time, and we estimate that each mouse fell into the water no more than 5 times per hour. If a mouse fell often enough such that it did not have a chance to dry, it was removed to a cage filled with novel objects and allowed to dry before being placed back onto the rotating platform. A previous CSR study that lasted 4 days (P25--P29) and used mice implanted with EEG electrodes found that total sleep time throughout the experiment was decreased by ∼70% ([@B11]). After CSR (or sleep *ad libitum*) mice were returned in their home cages (4 per cage), and continued to have access to novel objects (new sets of objects every morning) and running wheels until the end of the experiment at P65--P68. All mice gained weight between P21 (weaning day) and P30 (end of CSR), but controls did so more than CSR mice (C: +44.2 ± 12.2%; CSR: +20.7 ± 9.3%; *t* test, *p*\<0.0001), and in each group males grew more than females (C/F +34.8 ± 12.7%; C/M +51.1 ± 12.2%; *t* test, *p* = 0.007; CSR/F +15.8 ±9.8%; CSR/M +27.9 ±8.3%; *t* test, *p*=0.008).

Stereotaxic injection of AAV for anterograde axonal tracing {#s3C}
-----------------------------------------------------------

Surgery occurred over the course of 4 days (8 mice/day) between P44 and P47. Anterograde axonal tracing from MOs was performed by injecting AAV1.hSyn.eGFP.WPRE.bGH (1.79 × 10^13^ GC/mL) at two different depths using iontophoresis, which allows for small, focal injections ([@B18]). The day before surgery, glass capillary tubing was heat-pulled to create pipet tips that were then cut and verified under a microscope to obtain tip widths of 10--30 μm. Just prior to surgery, these pipets were filled with virus using capillary action to prevent formation of bubbles. Mice were anesthetized under 2% isoflurane and maintained at 1--2% isoflurane for the duration of surgery. Using sterile technique, mice were fitted into a stereotaxic frame and an incision was made to expose the skull. The skull was cleaned with saline and hydrogen peroxide, and a small burr hole was made in the skull using a dental drill. Any exposed brain was kept moist by saline at all times. The filled pipet was then prepared by lowering a silver wire into the pipet until it contacted virus. An electrical lead was attached to the silver wire, and an electrical ground was connected to a metal clip placed on the skin near the skull. The pipet was then lowered to the surface of the brain 1.7 mm anterior and 0.75 mm lateral (right) from bregma. From the cortical surface, the pipet tip was lowered through the dura and into the brain 0.4 mm. A pause of 2 min was given to allow for a weak seal to form between the brain and the glass of the pipet. Current was then delivered through the pipet tip at 3 μA, alternating 7 s on and 7 s off, and repeating for 5 min to inject viral particles. The pipet tip was then lowered another 0.4 mm (to a total depth of 0.8 mm from the surface of the cortex) and the 5 min current delivery was repeated. After the current was stopped, the pipet tip was kept in place 5 additional minutes to allow for any pressure to dissipate before removal of the tip. After removal of the tip, the incision was sealed using Vetbond, antibiotic gel was applied to the surgical site, and mice were removed from isoflurane. Mice were monitored daily for 7 days following surgery to ensure normal recovery. Two control mice experienced health issues in this period and were killed.

Perfusion {#s3D}
---------

Three weeks after surgery (P65--P68), mice (16 CSR and 14 controls) were deeply anaesthetized with isoflurane (3% volume) and perfused transcardially with a flush (∼30 s) of saline followed by 4% paraformaldehyde (PFA) in phosphate buffer (PB). Mice were then decapitated, and heads were kept in 4% PFA until shipping to the Allen Institute for serial two-photon tomography.

Serial two-photon tomography {#s3E}
----------------------------

Briefly, carefully dissected brains were prepared for serial two-photon (STP) tomography, which integrates optical imaging and vibratome sectioning, by first rinsing with PBS before embedding in an agarose block as previously described in detail ([@B33]). Images were acquired on TissueCyte 1000 2-photon systems (TissueVision) coupled with Mai Tai HP DeepSee lasers (Spectra Physics) using 925 nm wavelength light through a Zeiss 20× water immersion objective (NA = 1.0). One optical plane was imaged 75 µm below the cutting surface. After an entire section was imaged at an XY resolution of ∼0.35 µm/pixel, a 100 µm section was cut by the vibratome and then the specimen was returned to the objective for imaging of the next plane. Images from 140 coronal sections were collected to cover the full mouse brain. Data from one CSR mouse could not be used due to a problem in image alignment. Another CSR mouse was excluded due to problems during imaging, and thus the final analysis included 14 controls and 14 CSR mice.

Image data processing {#s3F}
---------------------

The Allen Institute informatics data pipeline managed processing and organization of the images and quantified data for analyses. Algorithms developed for the *Allen Mouse Connectivity Atlas* for signal detection and image registration were used on this dataset ([@B33]). Detailed descriptions of the neuroinformatics developed for segmentation and registration for this atlas were published recently ([@B24]). Briefly, the signal detection algorithm was applied to each image to segment positive fluorescent signals from background. Steps include low-pass filtering to remove noise, followed by adaptive edge/line detection and classification, then integration of the detected results and rejection of artifacts or outliers. For registration, as STP tomography results in inherently aligned section images, we can simply stack the section images together to form a coherent reconstructed 3D volume. Each image stack is first registered to an intermediate "template" brain, created by iteratively averaging across ∼1700 brains from the *Allen Mouse Connectivity Atlas*. Registration to this template occurs in two broad steps; global alignment followed by local alignment effected through a coarse-to-fine deformation registration. The final step is then to align to the 3D Allen Mouse Common Coordinate Framework model.

Project density estimation {#s3G}
--------------------------

After segmentation and registration, signal was quantified for each voxel (10 ×10 × 10 µm) in the reference space and for each structure in the ontology by combining voxels from the same structure in the 3D reference model.

Thresholding {#s3H}
------------

The regions that had mean projection fractions \<0.1% were removed from the comparison analysis because the signal was too weak to be reliable across mice. For the ipsilateral side of the injection, 56 regions were removed (237 remained) and 92 regions (201 remained) for the contralateral side.

Injection volume normalization {#s3I}
------------------------------

Due to the experimental difficulties in controlling for the injection volume in every animal, we sought to account for the differences by normalizing by a factor proportional to the injection volume. We observed that a direct division of the projection fractions by injection volumes was not suitable and resulted in a negative correlation between total projection fraction and injection volume (not shown). Thus, we proceeded to normalize the data by fitting a power law:$$\sum PF = A\left( {InjVol} \right)^{n} + B.$$

Where ∑*PF* is the sum of all projection fractions for an animal (after thresholding), *InjVol* is the injection volume, and (*A*, *B*, *n*) are constants. It can be seen that *B* = 0 as there will be no fluorescence signal in the absence of any injection. Taking the logarithm:$$\left. {\log\left( \sum PF \right)} = n{\log\left( InjVol \right.} \right)\, + {\log A}.$$

A linear regression fit allowed us to determine that *n* = 0.216 was optimal and hence all the projection fractions were divided by (*InjVol*)^*n*^. Note that once this normalization is done, the projection fraction values are no longer guaranteed to be ≤1.

General linear model {#s3J}
--------------------

A general linear model (GLM) was used to control for differences in the centroids of the injections. This was done on the data after having normalized by the injection volume as described above. For every region, a GLM was fit to see the effect of the group type (CSR or control) on the normalized projection fraction. To allow comparisons between regions, every region was normalized to have unit mean. This was followed by fitting the following GLM:$$PF_{i,j} = \beta_{j} + k_{xj}x_{i} + k_{yj}y_{i} + k_{zj}z_{i} + k_{cj}c_{i}.$$

Where *PF~i,\ j~* is the normalized projection fraction for animal *i* at region *j*, *x~i~* is the medial-lateral distance of the injection site from the midline for animal *i* after adjusting for all animals, such that $\overline{x_{i}} = 0$. $y_{i}$ corresponds to the anterior-posterior distance (from the anterior commissure) and $z_{i}$ to depth measurements (from the pia). $c_{i}$ corresponds to the condition of the animal, where control $= 1$ and CSR $= - 1$. The terms $k_{xj}$, $k_{yj}$, $k_{zj}$, and $k_{cj}$ are factors that capture the influence of their corresponding variable and are determined by maximum likelihood estimation with the MATLAB 2015b Statistics and Machine Learning Toolbox. $\beta_{j}$ is the intercept term of the GLM for every region $j$. It should be noted that if $k_{cj}$ is positive, then that indicates that control animals ($\left. c_{i} = 1 \right)$ will have an increased projection fraction due to their condition. The opposite is true if $k_{cj}\,$is negative. If $k_{cj}\, = 0$ then there is no effect due to the condition. Although our analysis shows that individually $k_{cj}$ values are not significant, we observe that all of the $k_{cj}$ values are positively biased with a positive mean ([Fig. 2*C*](#F2){ref-type="fig"}). The mean of all $k_{cj}$ values is called $\mu_{k_{c}}.$ However, the $\mu_{k_{c}} > 0$ result does not pass a bootstrap significance test as described below.

![Projection Fractions in Controls and CSR Mice. ***A***, A plot of projection fractions (normalized by injection volume) across all mice (*y*-axis) and all regions (*x*-axis). ***B***, Correlations of projection fraction patterns in mice with injection site. The mouse with the most extreme distance in injection location is taken as the basis for correlation (and is by definition equal to one). All regions were first normalized to have unit means to account for differences between injections. Without this normalization, the mean pairwise correlation of all animals is 0.903 ± 0.07. Distance in micrometers is measured to the center of the injection site from the midline (826 ± 140, left), the midline merging of the anterior commissure (1771 ± 262, middle) or the pial surface (636± 60, right). Values are given for Pearson's rho. ***C***, Left, Box plot of the condition influence, $k_{cj}$, of the GLM for all regions. A positive $k_{cj}$ indicates that the control group has a higher connectivity than the CSR group (see Results for details). Right, An expanded version that is aligned and color-coded to match the subdivision in major anatomical regions.](enu0021620430002){#F2}

Bootstrap test {#s3K}
--------------

To test the confidence of the positive $\mu_{k_{c}}$ result, we performed a bootstrap test on the data. Each group was separately resampled (with replacement) to create a total of 50 new data sets while maintaining the same size for each group. Thus, any single resampling case may have some animals selected multiple times and others not selected at all. This allowed for 2500 (50 CSR ×50 Control) comparisons where we determined the fraction of times that $\mu_{k_{c}}$ was negative as the *p* value. Note that every comparison involved determining a new GLM for every region. With these comparisons, the best *p* value that may be claimed is$\, 1/50^{2}$ though the attained *p* values were significantly larger. For the test where the female mice were investigated separately, $\mu_{k_{c}}$ changed sign ($\mu_{k_{c}}$$\left. \, < 0 \right)$ and hence the opposite one-tailed bootstrap was performed (ratio of positive $\mu_{k_{c}}$ to total number of comparisons).

Animal classification {#s3L}
---------------------

Machine learning techniques were implemented to classify the animals between CSR and control groups. This was done after fitting a modified GLM as described above that did not include a condition parameter. The dependence of the injection centroid for every animal was then subtracted such that, to the best of our knowledge, only condition was a factor in influencing projection fractions. The algorithms were trained on $n - 1$ animals and classification was tested on the excluded animal. This process was iterated and the classification performance was quantified as the ability to classify all animals in this manner. Using a standard logit-boost decision tree to minimize binomial deviance gave the best classification accuracy at 71% (8 errors). This was due to the large overlap between animal projection values, such that no specific regions were adequate to instantly determine whether there were differences between the two groups. Hence, to improve the performance, a preprocessing step as inspired by role-base similarity was applied ([@B3]). Here, correlations between all regions were calculated to generate a $237 \times 237$ correlation matrix (ipsilateral hemisphere only considered). The matrix was thresholded at zero to create a positive-only correlation matrix in addition to zeroing the diagonal. Multiscale clustering was achieved using the dynamics-based clustering framework of Markov Stability ([@B12]; [@B47]; [@B5]). The clustering algorithm used a Markov process to find clusters at different scales ([@B47]). Each cluster was then merged by summing each region within it. For instance, if a group of regions were grouped into a cluster, then for each animal the projection fractions were summed up to attain merged projection values for all regions in that cluster. At the different scales found by the Markov stability algorithm, a binary decision tree that minimizes the binomial deviance between a root node and targets was used to classify the compacted data (MATLAB 2015b Statistics and Machine Learning Toolbox). The classification improved to an accuracy of 82% (5 errors).

Anatomical analysis of MOs projections {#s3M}
--------------------------------------

Overall MOs projection pattern was highly consistent with what reported in the literature ([@B53]; [@B39]). Specifically, starting from the injection site in MOs, strong labeling was seen in fiber tracts extending rostrally and bilaterally into MOs, primary motor cortex, orbital area, and claustrum. Fibers weakly labeled were seen extending into the olfactory tubercle and surrounding olfactory areas bilaterally, including tenia tecta. All these bilateral projections were stronger in the hemisphere ipsilateral to the injection. Weak bilateral labeled fibers were also seen along the midline in the lateral septal nucleus and diagonal band nucleus, with roughly equal strength in both hemispheres. Moving caudally from the site of the injection, projections could be seen bilaterally in MOs, primary motor cortex and claustrum, and ipsilaterally in retrosplenial cortex. Ipsilateral primary and secondary somatosensory cortex was strongly labeled, especially in the deep and superficial layers (a similar pattern was seen in contralateral somatosensory cortex, but fluorescence was much weaker). Weak fluorescence was visible ipsilaterally in auditory and visual cortex and in postsubiculum, mostly in the deep layers, with weaker fluorescence in the same areas on the contralateral side. A reliable signal was visible across all layers in bilateral ectorhinal cortex. Fibers descended ventrally and bilaterally into caudate putamen, nucleus accumbens, and basolateral amygdala, as well as in the dorsal portion of the bed nucleus of the stria terminalis. Fibers also descended within the internal capsule toward the thalamus ipsilateral to the injection. Thalamic projections extended into rostral reticular thalamic nucleus, ventral posteromedial nucleus, ventral medial nucleus, and ventral anterior-lateral nucleus of the thalamus. More caudally, projections were visible bilaterally (but always stronger ipsilaterally) in central medial nucleus, ventral medial nucleus, mediodorsal nucleus, parafascicular nucleus, and rhomboid nucleus, whereas ipsilateral projections were present in central lateral nucleus and posterior complex. Very faint projections were sometimes visible in the hippocampus, usually along the medial dorsal border of CA1 and dentate gyrus. Further caudally, ipsilateral projections were seen in the zona incerta, subthalamic nucleus, parasubthalamic nucleus, substantia nigra, ventral tegmental area, and extended dorsally into retrorubral area, red nucleus, midbrain reticular nucleus, and superior colliculus. Much weaker projections were visible in the same areas contralaterally. Fibers were also visible in periaqueductal gray and midline nuclei including Edinger--Westphal nucleus and rostral linear nucleus raphe. Midline nuclei showed similar projection strength bilaterally, and projections to periaqueductal gray were visible bilaterally, although they were stronger ipsilaterally. Additionally, strongly labeled fibers were present in the cerebral peduncle along the ventral side of the brain in the ipsilateral hemisphere. Throughout the pons, diffuse projections were visible in roughly equal strength bilaterally, largely in the pontine reticular nucleus. Major projection fibers descended to the medulla via the pyramidal tract resulting in a similar diffuse projection pattern with bilateral weak projections to vestibular nuclei and stronger projections to ventral midline nuclei including raphe magnus, raphe pallidus, magnocellular reticular nucleus, parapyramidal nucleus, and inferior olivary complex. More caudally through the medulla, ipsilateral fibers begin to move contralaterally as the pyramidal tract decussates. To our knowledge, no projections to the hippocampus from MOs have been previously reported in rats or mice. We noted very faint traces of labeled projections in the most medial dorsal portions of the hippocampus along the borders of CA1. Though faint, these projections were visible in all mice. In general, because we expected that thin, distal projections would be more affected by CSR, we aimed at including as MOs targets all regions that showed labeled projections, even if those projections were sparse. To verify that thin projections were not a result of noise or false positives, and that other sparse projections were not lost to false negatives, we manually inspected positive signal masks generated after signal detection and compared them to fluorescence images in two mice. We found that the detected signal was highly concordant with observed fluorescence of all intensities, with very few false positives or negatives.

Statistics {#s3N}
----------

Values in the text and figures are reported as mean $\pm$ SD. Experiments were analyzed using two-tailed *t* tests, linear regression, a general linear model (see above), bootstrap test (see above), and computation of binomial cumulative distribution function probabilities. All *p* values $< 0.05$ were considered significant *a priori*. Analysis was performed in MATLAB and all statistical tests are summarized in [Table 1](#T1){ref-type="table"}.

###### 

Statistics

  **Property**                                                                        **Data Structure**                         **Type of test**                                                ***p* value**
  ----------------------------------------------------------------------------------- ------------------------------------------ --------------------------------------------------------------- ---------------
  [Fig 2B](#F2){ref-type="fig"}: medial--lateral effect on injections                 Normally distributed                       Student's *t* test                                              \<0.0001
  [Fig 2B](#F2){ref-type="fig"}: anterior--posterior effect on injections             Normally distributed                       Student's *t* test                                              0.004
  [Fig 2B](#F2){ref-type="fig"}: dorsal--ventral effect on injections                 Normally distributed                       Student's *t* test                                              0.796
  Control/CSR influence on connectivity ($\mu_{k_{c}}$ $> 0$)                         Normality not assumed                      One-tailed bootstrap                                            0.252
  Males: control/CSR influence on connectivity ($\mu_{k_{c}}$ $> 0$)                  Normality not assumed                      One-tailed bootstrap                                            0.491
  Females: control/CSR influence on connectivity ($\mu_{k_{c}}$ $< 0$)                Normality not assumed                      One-tailed bootstrap                                            0.258
  Control/CSR influence on weight (control \> CSR)                                    Normally distributed                       Paired *t* test                                                 \<0.0001
  Control: male/female weight gain (male \> female)                                   Normally distributed                       Paired *t* test                                                 0.007
  CSR: male/female weight gain (male \> female)Accuracy of classification algorithm   Normally distributedBinomial distributed   Paired *t* testBinomial cumulative distribution function test   0.0080.0005

Results {#s4}
=======

Mice of the same age from five litters were split into two groups ([Fig. 1*A*](#F1){ref-type="fig"}). One group was subjected to 5 days of CSR in the middle of early adolescence, from P25 to P30, using ecologically relevant stimuli (see Materials and Methods), whereas during the same period control siblings were allowed to sleep *ad libitum*. At the beginning of the experiment, each group included 16 mice, but two animals in each condition were excluded for various technical reasons (see Materials and Methods). The final analysis therefore included 14 controls and 14 CSR mice. Mice were not equipped with EEG electrodes to avoid potential damage to the cortex. However, based on continuous visual monitoring and a previous study with EEG recordings using similar sleep restriction methods ([@B11]), we estimate that overall sleep loss was between 50 and 60% (see Materials and Methods). Approximately 2 weeks later (P44--P47) CSR mice and controls were injected with recombinant adeno-associated virus (AAV)-expressing enhanced green fluorescent protein (EGFP) in the right MOs, to map its projections. We focused on MOs because it has diffuse projections ([@B63]) and is highly plastic ([@B8]). Exactly 3 weeks after each animal's injection the brains were perfused. Fluorescent signals were then imaged using serial two-photon tomography and informatically reconstructed within the Allen Mouse Common Coordinate Framework, a high-resolution coordinate system that allows the systematic analysis of the entire brain (see Materials and Methods; [@B33]).

As expected, robust anterograde tracing from right MOs was observed throughout the brain ([Fig. 1*B*](#F1){ref-type="fig"}). The overall pattern of projections was consistent across mice and similar to the one previously described for rat supplementary motor cortex, also known as medial agranular cortex ([@B53]; [@B39]). Briefly, strong projections were seen to orbital area, primary motor cortex, primary and secondary somatosensory cortex, claustrum, striatum, many thalamic nuclei, as well as zona incerta, ventral tegmental area, midbrain reticular nucleus, and several midline nuclei in the pons (see Materials and Methods for detailed anatomical description). Projections were always stronger, or only present, on the side of the injection, again consistent with previous studies showing that most MOs projections are ipsilateral ([@B53]; [@B39]). Thus, subsequent analyses primarily focused on the right side.

To identify potential differences in connectivity between CSR mice and controls we examined the projection fraction (also referred to as projection density) values for each brain structure that receives axonal projections from MOs. The projection fraction is defined as the total number of voxels that fluoresce in a target brain structure divided by the total number of voxels in that structure (see Materials and Methods). Hence, projection fraction is positive-only, has a maximal value of 1, and its use allows to control for differences in volume across anatomically defined regions. Note that the projection fraction includes both passing fibers and axon terminals, because they could not be differentiated informatically. Before direct comparisons between the two groups were made, projection fractions were normalized to control for small differences in injection volume across mice (see Materials and Methods). Moreover, regions with very weak signal were removed (projection fractions \<0.1%; see Materials and Methods). For the ipsilateral hemisphere, this thresholding resulted in dropping 56 regions from a total of 293, leaving 237 regions for analysis ([Table 2](#T2){ref-type="table"}). To avoid discarding genuine weak projections, we set the threshold for projection fraction fairly low. To ensure that signal within the weakest of the 237 regions was not simply due to false signal detection, detected signal overlays were compared to raw fluorescent images in two mice. Manual inspection in these mice confirmed that there were very few false positives and negatives, meaning that weak detected signals corresponded closely to real fluorescence. [Figure 2*A*](#F2){ref-type="fig"} visualizes the normalized and thresholded data for the two groups; every row corresponds to a different mouse injection into MOs and every column is a different region. The projection fraction from MOs to that brain region is plotted by color.

###### 

List of brain regions

  **Region no.**   **Region abbreviation**   **Region name**                                                      **Region category**
  ---------------- ------------------------- -------------------------------------------------------------------- -----------------------
  1                FRP                       Frontal pole, cerebral cortex                                        Isocortex
  2                MOp                       Primary motor area                                                   Isocortex
  3                MOs                       Secondary motor area                                                 Isocortex
  4                SSp-n                     Primary somatosensory area, nose                                     Isocortex
  5                SSp-bfd                   Primary somatosensory area, barrel field                             Isocortex
  6                SSp-ll                    Primary somatosensory area, lower limb                               Isocortex
  7                SSp-m                     Primary somatosensory area, mouth                                    Isocortex
  8                SSp-ul                    Primary somatosensory area, upper limb                               Isocortex
  9                SSp-tr                    Primary somatosensory area, trunk                                    Isocortex
  10               SSp-un                    Primary somatosensory area, unassigned                               Isocortex
  11               SSs                       Supplemental somatosensory area                                      Isocortex
  12               GU                        Gustatory areas                                                      Isocortex
  13               VISC                      Visceral area                                                        Isocortex
  14               AUDd                      Dorsal auditory area                                                 Isocortex
  15               AUDp                      Primary auditory area                                                Isocortex
  16               AUDpo                     Posterior auditory area                                              Isocortex
  17               AUDv                      Ventral auditory area                                                Isocortex
  18               VISal                     Anterolateral visual area                                            Isocortex
  19               VISam                     Anteromedial visual area                                             Isocortex
  20               VISl                      Lateral visual area                                                  Isocortex
  21               VISp                      Primary visual area                                                  Isocortex
  22               VISpl                     Posterolateral visual area                                           Isocortex
  23               VISpm                     Posteromedial visual area                                            Isocortex
  24               VISli                                                                                          Isocortex
  25               VISpor                                                                                         Isocortex
  26               ACAd                      Anterior cingulate area, dorsal part                                 Isocortex
  27               ACAv                      Anterior cingulate area, ventral part                                Isocortex
  28               PL                        Prelimbic area                                                       Isocortex
  29               ILA                       Infralimbic area                                                     Isocortex
  30               ORBl                      Orbital area, lateral part                                           Isocortex
  31               ORBm                      Orbital area, medial part                                            Isocortex
  32               ORBvl                     Orbital area, ventrolateral part                                     Isocortex
  33               AId                       Agranular insular area, dorsal part                                  Isocortex
  34               AIp                       Agranular insular area, posterior part                               Isocortex
  35               AIv                       Agranular insular area, ventral part                                 Isocortex
  36               RSPagl                    Retrosplenial area, lateral agranular part                           Isocortex
  37               RSPd                      Retrosplenial area, dorsal part                                      Isocortex
  38               RSPv                      Retrosplenial area, ventral part                                     Isocortex
  39               VISa                                                                                           Isocortex
  40               VISrl                                                                                          Isocortex
  41               TEa                       Temporal association areas                                           Isocortex
  42               PERI                      Perirhinal area                                                      Isocortex
  43               ECT                       Ectorhinal area                                                      Isocortex
  45               AOB                       Accessory olfactory bulb                                             Olfactory areas
  46               AON                       Anterior olfactory nucleus                                           Olfactory areas
  47               TT                        Taenia tecta                                                         Olfactory areas
  48               DP                        Dorsal peduncular area                                               Olfactory areas
  49               PIR                       Piriform area                                                        Olfactory areas
  50               NLOT                      Nucleus of the lateral olfactory tract                               Olfactory areas
  51               COAa                      Cortical amygdalar area, anterior part                               Olfactory areas
  57               CA3                       Field CA3                                                            Hippocampal formation
  59               FC                        Fasciola cinerea                                                     Hippocampal formation
  60               IG                        Induseum griseum                                                     Hippocampal formation
  61               ENTl                      Entorhinal area, lateral part                                        Hippocampal formation
  65               POST                      Postsubiculum                                                        Hippocampal formation
  66               PRE                       Presubiculum                                                         Hippocampal formation
  67               SUB                       Subiculum                                                            Hippocampal formation
  68               CLA                       Claustrum                                                            Claustrum + amygdala
  69               EPd                       Endopiriform nucleus, dorsal part                                    Claustrum + amygdala
  70               EPv                       Endopiriform nucleus, ventral part                                   Claustrum + amygdala
  71               LA                        Lateral amygdalar nucleus                                            Claustrum + amygdala
                                                                                                                  
  72               BLA                       Basolateral amygdalar nucleus                                        Claustrum + amygdala
  73               BMA                       Basomedial amygdalar nucleus                                         Claustrum + amygdala
  74               PA                        Posterior amygdalar nucleus                                          Claustrum + amygdala
  75               CP                        Caudoputamen                                                         Striatum + pallidum
  76               ACB                       Nucleus accumbens                                                    Striatum + pallidum
  77               FS                        Fundus of striatum                                                   Striatum + pallidum
  78               OT                        Olfactory tubercle                                                   Striatum + pallidum
  79               LSc                       Lateral septal nucleus, caudal (caudodorsal) part                    Striatum + pallidum
  80               LSr                       Lateral septal nucleus, rostral (rostroventral) part                 Striatum + pallidum
  83               SH                        Septohippocampal nucleus                                             Striatum + pallidum
  84               AAA                       Anterior amygdalar area                                              Striatum + pallidum
  86               CEA                       Central amygdalar nucleus                                            Striatum + pallidum
  87               IA                        Intercalated amygdalar nucleus                                       Striatum + pallidum
  88               MEA                       Medial amygdalar nucleus                                             Striatum + pallidum
  89               GPe                       Globus pallidus, external segment                                    Striatum + pallidum
  90               GPi                       Globus pallidus, internal segment                                    Striatum + pallidum
  91               SI                        Substantia innominata                                                Striatum + pallidum
  92               MA                        Magnocellular nucleus                                                Striatum + pallidum
  94               NDB                       Diagonal band nucleus                                                Striatum + pallidum
  96               BST                       Bed nuclei of the stria terminalis                                   Striatum + pallidum
  97               BAC                       Bed nucleus of the anterior commissure                               Striatum + pallidum
  98               VAL                       Ventral anterior-lateral complex of the thalamus                     Thalamus
  99               VM                        Ventral medial nucleus of the thalamus                               Thalamus
  100              VPL                       Ventral posterolateral nucleus of the thalamus                       Thalamus
  101              VPLpc                     Ventral posterolateral nucleus of the thalamus, parvicellular part   Thalamus
  102              VPM                       Ventral posteromedial nucleus of the thalamus                        Thalamus
  103              VPMpc                     Ventral posteromedial nucleus of the thalamus, parvicellular part    Thalamus
  104              SPFm                      Subparafascicular nucleus, magnocellular part                        Thalamus
  105              SPFp                      Subparafascicular nucleus, parvicellular part                        Thalamus
  106              SPA                       Subparafascicular area                                               Thalamus
  107              PP                        Peripeduncular nucleus                                               Thalamus
  108              MG                        Medial geniculate complex                                            Thalamus
  110              LP                        Lateral posterior nucleus of the thalamus                            Thalamus
  111              PO                        Posterior complex of the thalamus                                    Thalamus
  112              POL                       Posterior limiting nucleus of the thalamus                           Thalamus
  113              SGN                       Suprageniculate nucleus                                              Thalamus
  114              AV                        Anteroventral nucleus of thalamus                                    Thalamus
  115              AM                        Anteromedial nucleus                                                 Thalamus
  116              AD                        Anterodorsal nucleus                                                 Thalamus
  117              IAM                       Interanteromedial nucleus of the thalamus                            Thalamus
  118              IAD                       Interanterodorsal nucleus of the thalamus                            Thalamus
  119              LD                        Lateral dorsal nucleus of thalamus                                   Thalamus
  120              IMD                       Intermediodorsal nucleus of the thalamus                             Thalamus
  121              MD                        Mediodorsal nucleus of thalamus                                      Thalamus
  122              SMT                       Submedial nucleus of the thalamus                                    Thalamus
  123              PR                        Perireunensis nucleus                                                Thalamus
  124              PVT                       Paraventricular nucleus of the thalamus                              Thalamus
  125              PT                        Parataenial nucleus                                                  Thalamus
  126              RE                        Nucleus of reunions                                                  Thalamus
  127              RH                        Rhomboid nucleus                                                     Thalamus
  128              CM                        Central medial nucleus of the thalamus                               Thalamus
  129              PCN                       Paracentral nucleus                                                  Thalamus
  130              CL                        Central lateral nucleus of the thalamus                              Thalamus
  131              PF                        Parafascicular nucleus                                               Thalamus
  132              RT                        Reticular nucleus of the thalamus                                    Thalamus
  133              IGL                       Intergeniculate leaflet of the lateral geniculate complex            Thalamus
  134              LGv                       Ventral part of the lateral geniculate complex                       Thalamus
  135              SubG                      Subgeniculate nucleus                                                Thalamus
  137              LH                        Lateral habenula                                                     Thalamus
                                                                                                                  
  138              SO                        Supraoptic nucleus                                                   Hypothalamus
  140              PVH                       Paraventricular hypothalamic nucleus                                 Hypothalamus
  142              PVi                       Periventricular hypothalamic nucleus, intermediate part              Hypothalamus
  145              AVP                       Anteroventral preoptic nucleus                                       Hypothalamus
  147              DMH                       Dorsomedial nucleus of the hypothalamus                              Hypothalamus
  158              VLPO                      Ventrolateral preoptic nucleus                                       Hypothalamus
  160              LM                        Lateral mammillary nucleus                                           Hypothalamus
  161              MM                        Medial mammillary nucleus                                            Hypothalamus
  162              SUM                       Supramammillary nucleus                                              Hypothalamus
  163              TMd                       Tuberomammillary nucleus, dorsal part                                Hypothalamus
  164              TMv                       Tuberomammillary nucleus, ventral part                               Hypothalamus
  166              PMd                       Dorsal premammillary nucleus                                         Hypothalamus
  168              PVHd                      Paraventricular hypothalamic nucleus, descending division            Hypothalamus
  170              PH                        Posterior hypothalamic nucleus                                       Hypothalamus
  171              LHA                       Lateral hypothalamic area                                            Hypothalamus
  172              LPO                       Lateral preoptic area                                                Hypothalamus
  173              PST                       Preparasubthalamic nucleus                                           Hypothalamus
  174              PSTN                      Parasubthalamic nucleus                                              Hypothalamus
  176              STN                       Subthalamic nucleus                                                  Hypothalamus
  177              TU                        Tuberal nucleus                                                      Hypothalamus
  178              ZI                        Zona incerta                                                         Hypothalamus
  179              SCs                       Superior colliculus, sensory related                                 Midbrain + pons
  180              IC                        Inferior colliculus                                                  Midbrain + pons
  181              NB                        Nucleus of the brachium of the inferior colliculus                   Midbrain + pons
  182              SAG                       Nucleus sagulum                                                      Midbrain + pons
  183              PBG                       Parabigeminal nucleus                                                Midbrain + pons
  184              MEV                       Midbrain trigeminal nucleus                                          Midbrain + pons
  185              SNr                       Substantia nigra, reticular part                                     Midbrain + pons
  186              VTA                       Ventral tegmental area                                               Midbrain + pons
  187              RR                        Midbrain reticular nucleus, retrorubral area                         Midbrain + pons
  188              MRN                       Midbrain reticular nucleus                                           Midbrain + pons
  189              SCm                       Superior colliculus, motor related                                   Midbrain + pons
  190              PAG                       Periaqueductal gray                                                  Midbrain + pons
  191              APN                       Anterior pretectal nucleus                                           Midbrain + pons
  192              MPT                       Medial pretectal area                                                Midbrain + pons
  193              NOT                       Nucleus of the optic tract                                           Midbrain + pons
  194              NPC                       Nucleus of the posterior commissure                                  Midbrain + pons
  195              OP                        Olivary pretectal nucleus                                            Midbrain + pons
  196              PPT                       Posterior pretectal nucleus                                          Midbrain + pons
  197              CUN                       Cuneiform nucleus                                                    Midbrain + pons
  198              RN                        Red nucleus                                                          Midbrain + pons
  199              III                       Oculomotor nucleus                                                   Midbrain + pons
  200              EW                        Edinger--Westphal nucleus                                            Midbrain + pons
  201              IV                        Trochlear nucleus                                                    Midbrain + pons
  202              VTN                       Ventral tegmental nucleus                                            Midbrain + pons
  203              AT                        Anterior tegmental nucleus                                           Midbrain + pons
  204              LT                        Lateral terminal nucleus of the accessory optic tract                Midbrain + pons
  205              SNc                       Substantia nigra, compact part                                       Midbrain + pons
  206              PPN                       Pedunculopontine nucleus                                             Midbrain + pons
  207              IF                        Interfascicular nucleus raphe                                        Midbrain + pons
  208              IPN                       Interpeduncular nucleus                                              Midbrain + pons
  209              RL                        Rostral linear nucleus raphe                                         Midbrain + pons
  210              CLI                       Central linear nucleus raphe                                         Midbrain + pons
  211              DR                        Dorsal nucleus raphe                                                 Midbrain + pons
  212              NLL                       Nucleus of the lateral lemniscus                                     Midbrain + pons
  213              PSV                       Principal sensory nucleus of the trigeminal                          Midbrain + pons
  214              PB                        Parabrachial nucleus                                                 Midbrain + pons
  215              SOC                       Superior olivary complex                                             Midbrain + pons
  216              B                         Barringtons nucleus                                                  Midbrain + pons
                                                                                                                  
  217              DTN                       Dorsal tegmental nucleus                                             Midbrain + pons
  218              PCG                       Pontine central gray                                                 Midbrain + pons
  219              PG                        Pontine gray                                                         Midbrain + pons
  220              PRNc                      Pontine reticular nucleus, caudal part                               Midbrain + pons
  221              SG                        Supragenual nucleus                                                  Midbrain + pons
  222              SUT                       Supratrigeminal nucleus                                              Midbrain + pons
  223              TRN                       Tegmental reticular nucleus                                          Midbrain + pons
  224              V                         Motor nucleus of trigeminal                                          Midbrain + pons
  225              CS                        Superior central nucleus raphe                                       Midbrain + pons
  226              LC                        Locus ceruleus                                                       Midbrain + pons
  227              LDT                       Laterodorsal tegmental nucleus                                       Midbrain + pons
  228              NI                        Nucleus incertus                                                     Midbrain + pons
  229              PRNr                      Pontine reticular nucleus                                            Midbrain + pons
  230              RPO                       Nucleus raphe pontis                                                 Midbrain + pons
  231              SLC                       Subceruleus nucleus                                                  Midbrain + pons
  232              SLD                       Sublaterodorsal nucleus                                              Midbrain + pons
  236              CU                        Cuneate nucleus                                                      Medulla
  239              NTB                       Nucleus of the trapezoid body                                        Medulla
  240              NTS                       Nucleus of the solitary tract                                        Medulla
  241              SPVC                      Spinal nucleus of the trigeminal, caudal part                        Medulla
  242              SPVI                      Spinal nucleus of the trigeminal, interpolar part                    Medulla
  243              SPVO                      Spinal nucleus of the trigeminal, oral part                          Medulla
  244              VI                        Abducens nucleus                                                     Medulla
  245              VII                       Facial motor nucleus                                                 Medulla
  246              ACVII                     Accessory facial motor nucleus                                       Medulla
  247              AMB                       Nucleus ambiguus                                                     Medulla
  248              DMX                       Dorsal motor nucleus of the vagus nerve                              Medulla
  249              GRN                       Gigantocellular reticular nucleus                                    Medulla
  250              ICB                       Infracerebellar nucleus                                              Medulla
  251              IO                        Inferior olivary complex                                             Medulla
  252              IRN                       Intermediate reticular nucleus                                       Medulla
  253              ISN                       Inferior salivatory nucleus                                          Medulla
  254              LIN                       Linear nucleus of the medulla                                        Medulla
  255              LRN                       Lateral reticular nucleus                                            Medulla
  256              MARN                      Magnocellular reticular nucleus                                      Medulla
  257              MDRNd                     Medullary reticular nucleus, dorsal part                             Medulla
  258              MDRNv                     Medullary reticular nucleus, ventral part                            Medulla
  259              PARN                      Parvicellular reticular nucleus                                      Medulla
  260              PAS                       Parasolitary nucleus                                                 Medulla
  261              PGRNd                     Paragigantocellular reticular nucleus, dorsal part                   Medulla
  262              PGRNl                     Paragigantocellular reticular nucleus, lateral part                  Medulla
  263              NR                        Nucleus of Roller                                                    Medulla
  264              PRP                       Nucleus prepositus                                                   Medulla
  265              PPY                       Parapyramidal nucleus                                                Medulla
  266              LAV                       Lateral vestibular nucleus                                           Medulla
  267              MV                        Medial vestibular nucleus                                            Medulla
  268              SPIV                      Spinal vestibular nucleus                                            Medulla
  269              SUV                       Superior vestibular nucleus                                          Medulla
  270              x                         Nucleus x                                                            Medulla
  271              XII                       Hypoglossal nucleus                                                  Medulla
  272              y                         Nucleus y                                                            Medulla
  273              RM                        Nucleus raphe magnus                                                 Medulla
  274              RPA                       Nucleus raphe pallidus                                               Medulla
  275              RO                        Nucleus raphe obscurus                                               Medulla
  290              FN                        Fastigial nucleus                                                    Cerebellum
  291              IP                        Interposed nucleus                                                   Cerebellum
  292              DN                        Dentate nucleus                                                      Cerebellum
  293              fiber tracts              Fiber tracts                                                         Fiber tracts

A challenge in the outlined experiments is the difficulty in precisely replicating the injection site position. To determine the effect of such variations, plots of the mouse projection correlations relative to the mice with the injections farthest from the anatomical landmark for each axis are shown in [Figure 2*B*](#F2){ref-type="fig"}. Note the farthest injected mouse, for instance most distant from the midline, has a perfect correlation of 1 as it is compared with itself. As can be seen there is a strong dependence relative to the injected medial-lateral position (*r* = 0.954). Similar patterns could be observed for the other dimensions ([Fig. 2*B*](#F2){ref-type="fig"}). We emphasize that in determining the correlation for [Figure 2*B*](#F2){ref-type="fig"}, we normalize by the mean of every region (to have unit mean) to account for differences between injections, which is why we observe negative correlation values. Without this normalization and using solely the heat map in [Figure 2*A*](#F2){ref-type="fig"} gives a high mean pairwise correlation between all injections (0.903 ± 0.07). The effect also showed site specificity where, for instance, the anterior--posterior axis had a strong relationship in the isocortex (*r* = 0.602) and a significant influence by the depth axis was seen in the olfactory areas (*r* = 0.340). To account for this experimental variance, a GLM was fit to the normalized unit-mean projection fraction for every region (see Materials and Methods for more details). In the GLM, the effect of condition (Control or CSR) on a specific region is captured by a parameter $k_{cj}$, where, by construction, if $k_{cj}$ is positive then the control group has a higher projection fraction to region $j$ relative to the CSR group and vice versa. We found that $k_{cj}$ was not significant on a region level, though the distribution of $k_{cj}$ values did appear more positively biased with a positive mean ([Fig. 2*C*](#F2){ref-type="fig"}, left). However, running a bootstrap to test this effect yielded nonsignificant results ($\mu_{k_{c}} = 0.026$, $p = 0.252$; see Materials and Methods). Observing the distribution of $k_{c}$ across the different macro-regions ([Fig. 2*C*](#F2){ref-type="fig"}, right) indicates that certain brain regions may be more affected than others by sleep restriction. Once again, however, none of the divisions considered passed the bootstrap significance test. Performing the same analysis on the contralateral side yielded similar results.

To determine whether there were sex-specific differences, we performed the same analysis on the males and female animals separately. This was possible as we had a similar number of males and females (14 males, 8 controls; 15 females, 6 controls). Our results show that the sleep deprivation paradigm did not influence the males' ($\mu_{k_{c}} = 0.013$,$\, p = 0.491$) nor the females' ($\mu_{k_{c}} = -0.034$,$\, p = 0.258$) mesoscale connectivity. Due to the small number of animals, however, we cannot rule out that subtle effects do exist that we are unable to detect.

We also investigated whether we could use the MOs normalized projection fractions (adjusted for injection positions; see Materials and Methods) to classify animals using machine-learning techniques. We trained classification algorithms on all but one animal, used the algorithm to predict the group of the excluded mouse, and repeated the procedure for all mice. We then evaluated the performance of our algorithm by its ability to classify all 28 mice. The best performance we could attain on the normalized data was 71% (8 errors; see Materials and Methods for details). To see if we could improve classification accuracy, we applied a preprocessing step as inspired by a newly developed graph-theory technique termed role-base similarity ([@B3]; see Materials and Methods). Briefly, we found the positive correlations between all regions to create a positive-only correlation matrix that was then clustered at different levels of granularity using a Markov stability algorithm ([@B12]; [@B47]; [@B5]). By considering different levels of granularity and using classification tree algorithms on the compacted data, we reached a classification accuracy of 82% (5 errors; see Materials and Methods). Because the classification problem is binomial in nature, the classification accuracy corresponds to a *p* value of 0.0005 (determined from a binomial cumulative distribution function with 5 errors, 28 attempts, at a probability of 0.5). This indicates that although CSR does not affect the brain in a single homogenous direction, it does have an intricate heterogeneous effect that can be captured by machine learning classification. Overall, the variability observed in the decision trees from dropping animals did not show a clear hypothesis for *post hoc* testing. Nonetheless, we conclude that long-term changes in brain connectivity at the mesoscopic level do occur, and further investigations are required to fully uncover the differences.

Discussion {#s5}
==========

To our knowledge, this is the first study that tested whether there are structural changes in the adult mammalian brain after sleep was restricted during early adolescence. Brains were collected soon after mice reached adulthood, but younger mice were not tested. Thus, there may have been acute effects of CSR that we missed. Our goal, however, was to search for late, possibly irreversible effects of sleep loss on the adult connectivity. We found some evidence that early adolescence may affect the adult brain connectivity, but the changes were subtle and heterogeneous. This finding may be a true biological result, and/or it may reflect the technical limitations of our approach. The method implemented here was never used before to compare projection strength across animals in response to a behavioral manipulation. Moreover, it is based on a measure of "projection density" that combines both fibers of passage and axonal terminals and thus specific effects on the terminals may have been missed and may be better assessed using array tomography combined with excitatory and inhibitory presynaptic and postsynaptic markers ([@B59]). We note, however, that the method was sensitive enough to be significantly affected by small changes in the injection site along the medial--lateral or anterior--posterior axes, which led in some cases to noticeable differences in projection fraction profiles across animals. Finally, another limitation of the study is that we targeted a high-order area that is presumably still undergoing synaptic refinement during early adolescence, but only a systematic analysis of many brain regions can assess the full extent of the effects of chronic sleep loss.

Epidemiological studies consistently find that adolescents build a chronic sleep debt during the school days, which they are assumed to "repay" during the weekends by sleeping 1--2 hours longer ([@B60]; [@B41]; [@B25]). Our protocol of chronic sleep restriction was quite severe but relatively short lasting (50--60% sleep loss for 5 days), but whether the milder but repeated pattern of sleep restriction observed in humans impairs the maturation of brain circuits is unknown. The inter-individual variability of the structural effects of chronic sleep loss in adolescents is also unknown, but adults vary in their susceptibility to the cognitive impairment caused by sleep deprivation ([@B57]; [@B44]), and differences in the microstructure of white and grey matter can predict inter-individual differences in the resistance to sleep loss ([@B40]; [@B9]; [@B4]).

We investigated the effect of gender in our study because sex differences in sleep exist in both humans and rodents ([@B31]): relative to males, adult female C57BL/6J mice (the strain used in the current study) are awake ∼1.5 hours more per day, recover relatively more sleep after acute sleep deprivation ([@B34]), and respond to restraint stress with a smaller rebound in REM sleep ([@B35]). Moreover, CSR mice were kept awake using mild forced locomotion, exposure to novel objects and social enrichment. None of these methods is routinely used in chronic variable stress paradigms. Yet, sleep is tightly homeostatically regulated and sleep pressure becomes irresistible even after just a few hours of extended wake ([@B6]). Thus, extending wake beyond its physiological duration is inherently stressful, and chronic sleep loss in male adult rats leads to increased levels of catecholamines, and to a lesser extent, ACTH and glucocorticoids ([@B38]). The behavioral effects of stress are sexually dimorphic. For instance, C57BL/6J mice that were kept awake by gentle handling for 3 hours daily from P5 to P42 show changes in sociability and repetitive behavior (but not in anxiety measures) when tested as adults, and these effects differ between males and females ([@B46]). The structural effects of chronic stress are also sexually dimorphic in rodent prefrontal cortex and hippocampus, with loss of dendritic spines only seen in males but not in females ([@B26]), although the underlying mechanisms are unclear and may include different sensitivity to glucocorticoids ([@B16]; [@B26]), and/or differences in the response to other hormones and neurotransmitters involved in stress and arousal, including glutamate or noradrenaline ([@B56]). Because our two groups of mice included a similar number of males and females (14 males, 8 controls; 14 females, 6 controls) we specifically test for any sex-related difference in our findings, but could not find any. However, we cannot rule out that the number of animals may have been too small to detect subtle differences.

Loss of sleep is associated with cellular stress, impaired protein synthesis, and increased energy demand ([@B28]; [@B58]; [@B6]; [@B11]), consistent with a general anabolic role for sleep. Although all mice gained weight between P21 (weaning) and P30 (end of CSR), controls did so more than CSR mice (gain weight in grams, C: +44.2 ± 12.2%; CSR: +20.7 ± 9.3%; *t* test, *p* \< 0.001). Of note, in each group males gained more weight than females, almost twice as much in the CSR group, suggesting that CSR affected body growth more in females than males (Controls/F +34.8 ± 12.7%; Controls/M +51.1 ± 12.2%; *t* test, *p* = 0.007; CSR/F +15.8 ± 9.8%; CSR/M +27.9 ± 8.3%; *t* test, *p* = 0.008). Independent of the body however, growth and maintenance of neural circuits is energetically expensive and requires continuous protein synthesis ([@B21]; [@B27]). Of note, a recent study subjected flies to total sleep deprivation for 36 hours starting soon after eclosion and tested them as "young adults" (5 days old; [@B20]). In these male flies, courtship behavior was impaired, and the volume of one specific olfactory glomerulus was reduced ([@B20]). Intriguingly, this glomerulus was the one showing the largest growth after eclosion, suggesting that the most rapidly maturing brain regions are uniquely sensitive to sleep deprivation ([@B20]). It is possible, therefore, that had we tested younger mice, we would have found more severe permanent structural effects caused by early chronic sleep loss.

Synthesis {#s6}
=========

The decision was a result of the Reviewing Editor Rae Silver and the peer reviewers coming together and discussing their recommendations until a consensus was reached. A fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision is listed below. The following reviewer(s) agreed to reveal their identity: James Krueger

General comments

The manuscript investigates an important subject that many have opinions about but there is little data in support. That being that chronic sleep loss in adolescents is associated with long-term brain anatomical changes. This is a very well written and executed manuscript. There is a real possibility however, that the approach used to detect structural changes might have failed to detect any changes of any kind no matter what the perturbation. If the authors were to show a positive control, this would confirm that the approach works, and would confirm that the lack of structural change after CSR is a real effect. A positive control would add much to the paper and to conclusions that would be widely disseminated given the broad interest in the subject. Ideally, the authors would show in a brain region for which CSR (or sleep deprivation) has a known impact that this method can detect the change. If not, perhaps the method is not suited to draw any conclusions, and the absence of an effect could be methodological, not biological. This represents a substantial caveat.\"

Specific comments

1\) Please indicate the number of times mice entered the water during deprivation; the ambient temperature (23 degrees)is well below thermoneutral temperatures for mice and if they were wet it would amplify the thermochallenge.

2\) First half of the second paragraph of the Discussion - omit. Trying to make such comparisons between mice and men is pure speculation.
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